The European Patent Office has issued a notification of Intention to Grant a patent for the PD1-Vaxx cancer vaccine of Imugene Ltd (ASX:IMU, OTC:IUGNF). The.
The receipt of the patent confirms the innovation and uniqueness of the Company's technologies and strengthens its position as a leader in the cannabis space TEL AVIV, Israel, Oct. 03, 2023 (GLOBE NEWSWIRE) SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that The European Patent Office has granted it a new patent
Shares of SciSparc Ltd. (SPRC) are up 38% on Tuesday following the announcement of a new patent granted by the European Patent Office. SPRC is trading on the Nasdaq at $5.